Neo Exchange Inc.

Psychedelics appear to be here to stay. Yet stocks, shares and finance are another story. On August 4, publicly traded clinical-stage psychedelics firm Mind Medicine Inc. (NASDAQ: MNMD) announced its board of directors has approved a ratio of 1:15 reverse share split of its common shares....